NPY and prostate carcinoma: The expressions of NPY and Y1R, Y2R and Y5R have been studied in benign prostate, primary prostate cancer, and primary prostate cancer bone metastases; moreover, a transwell migration study on the LNCaP primary prostate cancer cell line was carried out to elucidate the chemotactic characteristics of NPY [242].